Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 13 of the 37 sources its claims cite were checked for support.

Evaluating the effectiveness of combined T4 and T3 therapy or desiccated thyroid versus T4 monotherapy in hypothyroidism: a systematic review and meta-analysis

Open access

Abstract

Background: Persistent symptoms in hypothyroid patients despite normalized TSH levels suggest the need for alternative treatments. This study aims to evaluate the effectiveness of combined T4 and T3 therapy or desiccated thyroid (DTE) compared to T4 monotherapy, with a focus on thyroid profile, lipid profile, and quality of life metrics. Methods: We conducted a systematic review in Embase, Medline/PubMed, and Web of Science up to 11/23/2023. We used the following keywords: “Armour Thyroid,” OR “Thyroid extract,” OR “Natural desiccated thyroid,” OR “Nature-Throid,” “desiccated thyroid,” OR “np thyroid,” OR “Synthroid,” OR “levothyroxine,” OR “Liothyronine,” “Cytomel,” OR “Thyroid USP,” OR “Unithroid.” AND “hypothyroidism. “ We only included RCTs and excluded non-RCT, case–control studies, and non-English articles. Results: From 6,394 identified records, 16 studies qualified after screening and eligibility checks. We included two studies on desiccated thyroid and 15 studies on combined therapy. In this meta-analysis, combination therapy with T4 + T3 revealed significantly lower Free T4 levels (mean difference (MD): -0.34; 95% CI: -0.47, -0.20), Total T4 levels (mean difference: -2.20; 95% CI: -3.03, -1.37), and GHQ-28 scores (MD: -2.89; 95% CI: -3.16, -2.63), compared to T4 monotherapy. Total T3 levels were significantly higher in combined therapy (MD: 29.82; 95% CI: 22.40, 37.25). The analyses demonstrated moderate to high heterogeneity. There was no significant difference in Heart Rate, SHBG, TSH, Lipid profile, TSQ-36, and BDI Score. Subjects on DTE had significantly higher serum Total T3 levels (MD: 50.90; 95% CI: 42.39, 59.42) and significantly lower serum Total T4 (MD: -3.11; 95% CI: -3.64, -2.58) and Free T4 levels (MD: -0.50; 95% CI: -0.57, -0.43) compared to T4 monotherapy. Moreover, DTE treatment showed modestly higher TSH levels (MD: 0.49; 95% CI: 0.17, 0.80). The analyses indicated low heterogeneity. There was no significant difference in Heart Rate, SHBG, Lipid profile, TSQ-36, GHQ-28, and BDI Score. Conclusions: Our study revealed that combined therapy and DTE lead to higher T3 and lower T4 levels, compared to T4 monotherapy in hypothyroidism. However, no significant effects on heart rate, lipid profile, or quality of life were noted. Given the heterogeneity of results, personalized treatment approaches are recommended.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis of RCTs found that combined T4+T3 therapy and desiccated thyroid extract (DTE) produce higher T3 and lower T4 levels than T4 monotherapy in hypothyroidism, without consistent significant effects on heart rate, lipids, or most quality-of-life measures. The authors conclude that biochemical differences do not clearly translate into broad clinical benefits and recommend personalized treatment approaches.

Key findings

  • Combined T4+T3 vs T4 monotherapy: significantly lower Free T4 (MD −0.34; 95% CI −0.47 to −0.20), Total T4 (MD −2.20; 95% CI −3.03 to −1.37), and higher Total T3 (MD 29.82; 95% CI 22.40 to 37.25). TSH did not differ significantly (MD 0.20; 95% CI −0.63 to 1.04; P=0.63).
  • Combined T4+T3 showed no significant differences in heart rate, SHBG, LDL, total cholesterol, HDL, triglycerides, TSQ-36, or BDI. The abstract reports significantly lower GHQ-28 scores (MD −2.89; 95% CI −3.16 to −2.63), but the Results text and Table 1 report GHQ-28 MD 1.71 (95% CI −1.82 to 5.23; P=0.34) and describe no significant impact; the Discussion nonetheless states a notable mental-health improvement.
  • DTE vs T4 monotherapy: significantly higher Total T3 (MD 50.90; 95% CI 42.39 to 59.42), lower Total T4 (MD −3.11; 95% CI −3.64 to −2.58), lower Free T4 (MD −0.50; 95% CI −0.57 to −0.43), and modestly higher TSH (MD 0.49; 95% CI 0.17 to 0.80).
  • DTE showed no significant differences in heart rate, SHBG, lipid profile, TSQ-36, GHQ-28, BDI, or cognitive/mental-health scores; heterogeneity was generally low for DTE analyses.

Methods

  • Systematic review and meta-analysis registered in PROSPERO (CRD42023486957), searching Embase, Medline/PubMed, and Web of Science up to 23 November 2023.
  • Included randomized controlled trials of adults ≥18 years with primary hypothyroidism receiving combined T4/T3 or DTE versus levothyroxine; excluded non-RCTs, case–control studies, pregnancy/pediatric patients, and non-English articles.
  • From 6,394 records, 16 studies qualified; the abstract describes two DTE studies and 15 combined-therapy studies. Mean differences with 95% CIs were pooled in RevMan, with heterogeneity assessed by I².

Limitations

  • The paper states high heterogeneity in some outcomes, potential language bias from excluding non-English studies, and concerns about publication bias; risk-of-bias assessment found high risk in blinding and incomplete outcome data domains.
  • The text makes evident that DTE conclusions rest on only two RCTs, and the GHQ-28 result is reported inconsistently across the abstract, Results, Table 1, and Discussion.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12902-024-01612-6

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 PRISMA Flow diagram of literature search and study selection process
Fig. 1 PRISMA Flow diagram of literature search and study selection processCC BY · PubMed Central
Fig. 2 Forest plots illustrating the effects of combined T4 + T3 therapy vs. T4 monotherapy on TSH, Total T4, Free T4, Total T3, Heart rate, and SHBG levels
Fig. 2 Forest plots illustrating the effects of combined T4 + T3 therapy vs. T4 monotherapy on TSH, Total T4, Free T4, Total T3, Heart rate, and SHBG levelsCC BY · PubMed Central
Fig. 3 Forest plots illustrating the effects of combined T4 + T3 Therapy vs. T4 Monotherapy on lipid profiles, quality of life, and mental health outcomes
Fig. 3 Forest plots illustrating the effects of combined T4 + T3 Therapy vs. T4 Monotherapy on lipid profiles, quality of life, and mental health outcomesCC BY · PubMed Central
Fig. 4 Forest plots illustrating the effects of DTE therapy vs. T4 monotherapy on lipid profiles, quality of life, and mental health outcomes
Fig. 4 Forest plots illustrating the effects of DTE therapy vs. T4 monotherapy on lipid profiles, quality of life, and mental health outcomesCC BY · PubMed Central
Fig. 5 Forest plots illustrating the effects of DTE therapy vs. T4 monotherapy on lipid profiles, quality of life, and mental health outcomes
Fig. 5 Forest plots illustrating the effects of DTE therapy vs. T4 monotherapy on lipid profiles, quality of life, and mental health outcomesCC BY · PubMed Central
Fig. 6 Forest plots illustrating the effects of DTE therapy vs. T4 monotherapy on IMI and DMI
Fig. 6 Forest plots illustrating the effects of DTE therapy vs. T4 monotherapy on IMI and DMICC BY · PubMed Central

Verification

Claims the paper makes

10 Valid · 0 Not valid · 8 Not checked · 97 Own results and interpretations

66 more claims

Create a free account to see all 115 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 27
  • It may state two separate claims as one. 18
  • The quote only partly states this claim. 5

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 5

Citations

Cites

Show all 32 references

Cited by

See all 12

Metadata

Authors
Nassar, M., Hassan, A., Ramadan, S., Desouki, M. T., Hassan, M. A., & Chaudhuri, A.
Affiliations
  • Beni-Suef University (EG)
  • Suez University (EG)
  • Ain Shams University (EG)
  • Alexandria University (EG)
  • University at Buffalo, State University of New York (US)
Corresponding author
Hassan, Ahmed
Venue
BMC Endocrine Disorders
Published
2024-06-14
Volume
24
Issue
1
Pages
90-90
ISSN
1472-6823 (ISSN-L)
OpenAlex
W4399690792
Cited by
12
References
32
Citations by year
2026: 5 · 2025: 6 · 2024: 1
FWCI
0.70
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Endocrine Disorders (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
hypothyroidism, desiccated thyroid extract, levothyroxine, liothyronine, free thyroxine, total T3, thyroid hormone levels, quality of life, lipid profile, thyroid-stimulating hormone, symptom scores, treatment effectiveness comparison
MeSH terms
Drug Therapy, Combination, Humans, Hypothyroidism, Quality of Life, Thyroid Gland, Thyroxine, Triiodothyronine, Treatment Outcome, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluating the effectiveness of combined T4 and T3 therapy or desiccated thyroid versus T4 monotherapy in hypothyroidism: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/s12902-024-01612-6
The paper
Nassar, M., Hassan, A., Ramadan, S., Desouki, M. T., Hassan, M. A., & Chaudhuri, A. (2024). Evaluating the effectiveness of combined T4 and T3 therapy or desiccated thyroid versus T4 monotherapy in hypothyroidism: a systematic review and meta-analysis. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-024-01612-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.